baber/WOPTO huggingface dataset:
Patent NZ-223093-A (NZ)
Title: Segmented assembly for use in making ceramic composite structures and method of using the same
Inventor: NEWKIRK MARC STEVENS
IPC: C04B35/65
Filed: 1988-01-06
Abstract: An assembly for the preparation of ceramic composite structures includes a segmented container (12) within which a permeable filler is retained and a parent metal body (20) is contacted with the bed (18) of permeable filler. The segmented container (12) is comprised of one or more segments made of a material, such as an Inconel alloy, which has a coefficient of thermal expansion which is significantly greater than that of the filler. The segments are arranged to define between or among them one or more expansion joints which are effective to accommodate circumferential thermal expansion of the segments to thereby inhibit or prevent volumetric expansion of the container (12). A method of forming ceramic composite structures includes heating the resulting assembly to melt and oxidize the parent metal, (20), e.g., aluminum, to form a polycrystalline material comprising an oxidation reaction product which grows through the mass of filler to embed it and thus form the composite structure.
Patent NZ-233502-A (NZ)
Title: 4-(1,2,4-triazole- or imidazole-phenyl-substituted) -1-(1,3-dioxolan-4-ylmethoxyphenyl) piperazine derivatives; preparatory processes: fungicidal and antiviral compositions
Inventor: HEERES JAN
IPC: C07D521/00
Filed: 1990-04-30
Abstract: 4-[4-[4-[4-[[2-(2,4-difluorophenyl)-2-(1H-azolylmethyl)-1,3-dioxolan-4 -yl]methoxy]pheny l ]-1-piperazinyl]phenyl]triazolones and imidazolones of formula <CHEM>  wherein  Q is CH or N;  Y is a radical of formula <CHEM> R<1> is C5-7cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC1-4alkyl; and R<2> is C1-6alkyl, C5-7cycloalkyl or mono-, di-, tri-, tetra- or pentahaloC1-4alkyl, the acid addition salts and stereoisomeric forms thereof; said compounds having antifungal properties. Pharmaceutical compositions containing such compounds as an active ingredient; methods of preparing said compounds and pharmaceutical compositions.
Patent NZ-238609-A (NZ)
Title: Polycyclic guanine derivatives; preparation, pharmaceutical compositions,
Inventor: NEUSTADT BERNARD R
IPC: C07D487/20
Filed: 1991-06-19
Abstract: PCT No. PCT/US91/04154 Sec. 371 Date Dec. 14, 1992 Sec. 102(e) Date Dec. 14, 1992 PCT Filed Jun. 20, 1991 PCT Pub. No. WO91/19717 PCT Pub. Date Dec. 26, 1991.Novel polycylic guanine derivatives of the formula:    <IMAGE>  (I)  and   <IMAGE>  (I')  wherein J is oxygen or sulfur, R1 is hydrogen, alkyl or alkyl substituted with aryl or hydroxy; R2 is hydrogen, aryl, heteroaryl, cycloalkyl, alkyl or alkyl substituted with aryl, heteroaryl, hydroxy, alkoxy, amino, monoalkyl amino or dialkylamino, or -(CH2)mTCOR20 wherein m is an integer from 1 to 6, T is oxygen or -NH- and R20 is hydrogen, aryl, heteroaryl, alkyl or alkyl substituted with aryl or heteroaryl; R3 is hydrogen, halo, trifluoromethyl, alkoxy, alkylthio, alkyl, cycloalkyl, aryl, aminosulfonyl, amino, monoalkylamino, dialkylamino, hydroxyalkylamino, aminoalkylamino, carboxy, alkoxycarbonyl or aminocarbonyl or alkyl substituted with awl, hydroxy, alkoxy, amino, monoalkylamino or dialkylamino; Ra, Rb, Rc, and Rd are defined in the specification; and n is zero or one. The compounds of formulas (I) and (I') are useful as antihypertensive, muscle relaxant and bronchodilating agents.
Patent NZ-244566-A (NZ)
Title: Food products and flavouring compositions containing
Inventor: DUBY PHILIPPE
IPC: A23L27/20
Filed: 1992-09-30
Abstract: 2-Carbomethoxy-1-pyrroline is used as a flavoring agent for food products.
Patent NZ-245405-A (NZ)
Title: Mosfet rectifier for non-resonant voltage switched converters
Inventor: GRAS TREVINO JOSE MARIA
IPC: H02M3/335
Filed: 1992-12-08
Abstract: Applicable to non-resonant switched mode power supplies with voltage regulation by means of pulse width modulation. Its objective is to achieve a reduction in the amplification in the value of input capacitance (Miller effect) at the instants of switching of the MOSFET rectifier transistors, and to prevent the appearance of a shortcircuit in the main power supply unit at such instants. The first of these objectives is achieved by having the switching of the MOSFET rectifier transistors take place at a value of drain-source voltage equivalent to the cathode to anode voltage drop of a conducting diode (approximately zero volts). The second objective is achieved assuring that change of state from cutoff to conduction, or vice versa, of the MOSFET rectifier transistors never occurs simultaneously with the change of state of the other switches in the converter. <IMAGE>
Patent NZ-251732-A (NZ)
Title: Flask for spraying liquid; details regarding nozzle structure
Inventor: LEROUX BRUNO
IPC: B65D47/20
Filed: 1993-04-08
Abstract: A flask having a flow-reducing nozzle, where said flask (4) contains a low or medium viscosity liquid (5) to be sprayed onto a surface, and where the flow-reducing nozzle includes a tubular member (2) with a slit-shaped opening (3) at the end for spraying the liquid.
Patent NZ-286274-A (NZ)
Title: Dishwasher, spray arm rotatable about a wash pump impeller has an under surface open to provide an axial flow inlet for the pump
Inventor: SARGEANT ADRIAN ANTHONY
IPC: A47L15/23
Filed: 1992-12-18
Abstract: A dishwasher comprising: a wash chamber adapted to accommodate dishes and within which wash liquid is circulated, a rack within said chamber which supports dishes above the floor of said chamber, a rotatable spray arm having liquid discharge nozzles located in the bottom of said wash chamber under said rack, a pump which pressurises said spray arm with wash liquid, and mounting means located centrally in the floor of said chamber which rotatably supports said spray arm, said spray arm in turn comprising a hub portion and two diametrically opposed wing portions extending outwardly therefrom towards the side walls of said chamber, and said wing portions shaped such that they droop downwardly away from the hub portion.
Patent NZ-289421-A (NZ)
Title: Fungicidal compositions comprising greater than 70wt% of the r-enantiomer of metalaxyl or benalaxyl
Inventor: NUNINGER COSIMA
IPC: A01N43/08
Filed: 1995-06-30
Abstract: If the R-enantiomer of metalaxyl, furalaxyl or benalaxyl is used, this results in a markedly increased biodegradability of these plant fungicides in the soil and a higher activity on the plants, as compared with the data of the racemic active ingredients. Fungicidal compositions exhibiting said improved properties comprise either of these fungicides with a content of R-enantiomer of more than 70 percent by weight based on the total amount of active ingredient.
Patent NZ-292559-A (NZ)
Title: Preparation of racemic alpha-substituted 4-methylthiobutyric acids by enzymatic hydrolysis
Inventor: FAVRE-BULLE OLIVIER
IPC: C12R1/01
Filed: 1995-09-19
Abstract: PCT No. PCT/FR95/01196 Sec. 371 Date Mar. 20, 1997 Sec. 102(e) Date Mar. 20, 1997 PCT Filed Sep. 19, 1995 PCT Pub. No. WO96/09403 PCT Pub. Date Mar. 28, 1996A method for the enzymatic hydrolysis of racemic  alpha -substituted 4-methylthiobutyronitriles into racemic  alpha -substituted 4-methylthiobutyric acid using a nitrilase from Alcaligenes faecalis, Gordona terrae or Rhodococcus sp.
Patent NZ-308393-A (NZ)
Title: Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
Inventor: CAMDEN JAMES BERGER
IPC: C07D249/08
Filed: 1996-05-22
Abstract: 1,3-bis-triazolyl-2-propanol derivative of formula (I) or its pharmaceutically acceptable salts, metal complexes, ethers or esters thereof is used in the manufacture of a medicament for treating cancer. In formula (I) R1 is substituted alkyl, cycloalkyl, aryl, haloaryl or aralkyl. A unit dosage composition comprising 400 mg/kg of a 1,3-bis-triazolyl-2-propanol derivative of formula (I) or its pharmaceutically acceptable salts, metal complexes, ethers or esters thereof wherein R1 is substituted alkyl, cycloalkyl, aryl, haloaryl or aralkyl is disclosed.
Patent NZ-333115-A (NZ)
Title: Preparation of hydrophillic macromolecules in hydrophobic solvents such as medium chain monoglycerides and diglcerides
Inventor: NEW ROGER RANDAL CHARLES
IPC: A61K38/23
Filed: 1997-07-02
Abstract: Hydrophobic preparations useful as pharmaceutical delivery systems comprising: (i) an oil phase comprising one or more medium chain monoglycerides, such as Akoline MCMTM; (ii) at least one amphiphile, preferably including a phospholipid such as phosphatidyl choline; and (iii) a hydrophilic species, which may be a protein such as insulin or calcitonin or another macromolecule, solubilised or otherwise dispersed in the one or more glycerides.
Patent NZ-337637-A (NZ)
Title: A process for the crystallization of lactitol from aqueous lactitol solution
Inventor: NURMI JUHA
IPC: C07H15/04
Filed: 1998-03-02
Abstract: A process for the production of structurally pure lactitol crystal forms selected from the group consisting of lactitol anhydride, lactitol monohydrate, lactitol dihydrate and lactitol trihydrate. The crystallization is performed by cooling a lactitol solution from a temperature at or slightly below the highest temperature of the stability area of the respective crystalline lactitol form to a temperature at or slightly above the lowest temperature of the stability area of the crystalline lactitol form.  The stability areas being defined, respectively, within the temperature limits of 100 oC and 0 oC by the intersections of the solubility lines defined by the following equations (1) to (4):  anhydride: s/% = 59.6 + 0.3003 t/"C Eq.(l) monohydrate: s/% = 50.2 + 0.4346 t/"C Eq. (2) dihydrate: s/% = 39.7 + 0.6332 t/"C Eq.(3) trihydrate: s/% = 33.4 + 1.1482 t/"C Eq.(4) wherein: s is the solubility % (w/w) of each respective lactitol form calculated from the mass of lactitol and water as follows: weight of lactitol / (weight of lactitol + weight of water) x 100%; t is the temperature in oC; and by maintaining the supersaturation of said lactitol solution at a level of 1 to 8 % (w/w) above the solubility line of the respective lactitol form crystallizing in said area.
Patent NZ-501858-A (NZ)
Title: Chip card (SIM) with wireless communication interface
Inventor: BOUQUET HANSPETER
IPC: H04M1/72403
Filed: 1997-06-16
Abstract: A SIM (Subscriber Identity Module) chip card for cellular telephones contains a data processing system (20) with memory elements (200) for the storage of data containing at least subscriber identification data in a telephone network. Electric contacts (24) on the surface of the chip card make it possible to exchange data between the processing system (20) and a mobile terminal (1) into which the card can be removably inserted. The chip card contains at least one coil for establishing wireless communication between the processing system and a device 3 external to the said mobile terminal, under the control of the mobile terminal and without using the mobile communication facilities of the network.
Patent NZ-505790-A (NZ)
Title: Method for manufacturing sterilized corks involving microwave irradiation
Inventor: JAGER JENS
IPC: A61L2/12
Filed: 1999-01-14
Abstract: The bulk cork is, or corks are, subjected to microwave radiation of 2-1000 watts per kg over an interval of 2.5-30 min.  The preferred power is 50-200 watts per kg, in a conveyor oven operating continuously.  Water content is reduced from 12-15 wt% to 6-10 wt%.  Composite cork in manufacture is submitted to the microwave radiation for more rapid binder polymerization and setting.  In addition, stabilization of adhesive between natural cork sections is accelerated.
Patent NZ-518941-A (NZ)
Title: Electronic game with game feature
Inventor: BEKARIAN ARRAM
IPC: A63F9/00
Filed: 2002-05-13
Abstract: A gaming machine with a display and control means for enabling a player to initiate play for a main game (1) as well as a feature game associated with the main game and capable of being played after initiating play. The display shows the accumulation of player points during play, which is determined by a predetermined trigger event (2,3,4,5 and 6) occurring and the player may elect to play the feature game with the accumulated player points.
Patent NZ-522349-A (NZ)
Title: Non-psychotropic cannabinoids that afford neuroprotection by exhibiting anti-inflammatory and/or antioxidative and glutamate-receptor blocking mechanisms of action
Inventor: GARZON AARON
IPC: A61P25/00
Filed: 2001-06-22
Abstract: Non-psychotropic cannabinoids are disclosed and pharmaceutical compositions comprising these compounds are described for preventing neurotoxicity, neuroinflammation, immune or inflammatory disorders comprising as active ingredient the stereospecific (+) enantiomer, having (3S, 4S) configuration of Ä6 tetrahydrocannabinol type compounds. The compositions are particularly effective in alleviating and even preventing neurotoxicity due to acute injuries to the central nervous system, including mechanical trauma, compromised or reduced blood supply as may occur in cardiac arrest or stroke, or poisonings. They are also effective in the treatment of certain inflammatory disorders and chronic degenerative diseases characterized by neuronal loss and chronic pain including neuropathic pain.
Patent NZ-522727-A (NZ)
Title: Electrolytic cell for the production of aluminium and a method for maintaining a crust on a sidewall and for recovering electricity
Inventor: AUNE JAN ARTHUR
IPC: C25C3/08
Filed: 2001-05-29
Abstract: An electrolytic cell for the production of aluminum comprising of an anode (5) and an electrolytic tank (2) where the electrolytic tank (2) comprises an outer sidewall (3) made from steel and carbon blocks (4) in the bottom of the tank forming the cathode of the electrolytic cells. Inside the steel sidewall (3) of the electrolytic tank (2) consists of one or more evaporation cooled panels (7), and wherein high temperature, heat resistant and heat insulating material (6) is arranged between the evaporation cooled panels and the steel shell. The invention also includes a method for maintaining a crust (24) on the sidewall of the tank and for recovering heat from the cooling medium (10c) inside the panel (7) for transformation into electrical energy.
Patent NZ-524120-A (NZ)
Title: Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
Inventor: BARRETT STEPHEN DOUGLAS
IPC: C07C259/10
Filed: 2001-07-12
Abstract: A compound of formula I is described wherein R1 is hydrogen, halogen, or nitro; R2 and R3 are hydrogen or fluorine; R4 is hydrogen, iodine, bromine, chlorine, or fluorine; R5 is hydrogen, halogen, hydroxy, C1-8 alkyl, C1-8 alkoxy, trifluoromethyl, or cyano; n is 1 to 5; R6, R7, R8, R9, and R10 are independently hydrogen, C1-8 alkyl, C3-8 cycloalkyl, hydroxy, C1-8 alkoxy, perhalo(C1-3)alkyl, hydroxy(C1-8)alkyl, (C1-5)alkoxy(C1-5)alkyl, [(C1-4)alkyl]2 amino-methyl, (C2-7)heterocycle(C1-5)alkyl, or aryloxy(C1-5)alkyl, or may be independently joined to complete a 3-10 member cyclic ring optionally containing additional heteroatoms selected from the group consisting of 0, S, NH, and N-alkyl, wherein R7 and R8 are independently selected for n>1; Ra and Rb are independently hydrogen or C1-4 alkyl; W is O or NRa; R11 is hydrogen, C1-8 alkyl, C2-6 alkenyl, C3-8 cycloalkyl, hydroxy(C1-8)alkyl, (C1-5)alkoxy(C1-5) alkyl, phenyl, C2-7 heteroaryl, (C1-8)alkylcarbonyl, (phenyl)carbonyl, (phenyl)(C1-3 alkyl) carbonyl, or trifluoro(C1-6)alkyl; wherein the above alkyl, alkoxy, cycloalkyl, heteroaryl, and phenyl groups can be optionally substituted with between 1 and 5 substituents independently selected from the group consisting of hydroxy, amino, monoalkylamino, dialkylamino, halogen, cyano, (C1-3)alkoxy, COOR, OCORa, CONRaRb, NRaCORb, SO, SO2, SO4 and SO2NRaRb; and pharmaceutically acceptable salts. The compound is described to be used in the treatment of proliferative diseases such as cancer, restenosis, psoriasis, and atherosclerosis. A proviso explains that when R11 is phenyl and n is 1, W cannot be 0; and that the compound is not 5 -Bromo-N-(2-diethylamino-ethoxy)-3,4-difluoro-(4-iodo-2-methyl- phenylamino)-benzamide; 5-Bromo-N-(2-dimethylamino-propoxy)-3,4-difluoro-2-(4-iodo-2-methyl-phenylamino)-benzamide; or 5-Bromo-2-(2-chloro-4-iodo-phenylamino)-N-(2-dimethylamino-ethoxy)-3,4-difluoro-benzamide.
Patent NZ-524599-A (NZ)
Title: Fatty acid analogues for the treatment of proliferative skin disorders related to keratinocyte differentiation and proliferation
Inventor: BERGE ROLF
IPC: A61P17/12
Filed: 2001-09-27
Abstract: The use of fatty acid analogues of the formula (I), its salt or complex for the treatment and/or prevention of proliferative skin disorders, specifically for the inhibition of proliferation and/or differentiation of keratinocytes is disclosed: R1 ? [Xi ? CH2]n ? COOR2   (I) wherein R1 is: a C1-C24 alkene with one or more double bonds and/or with one or more triple bonds, and/or a C1-C24 alkyne, and/or a C1-C24 alkyl, or a C1-C24 alkyl substituted in one or several positions with one or more compounds selected from the group comprising fluoride, chloride, hydroxy, C1-C4 alkoxy, C1-C4 alkylthio, C2-C5 acyloxy or C1-C4 alkyl, and wherein R2 represents hydrogen or C1-C4 alkyl, and wherein n is an integer from 1 to 12, and wherein i is an odd number and indicates the position relative to COOR2, and wherein Xi independent of each other are selected from the group comprising O, S, SO, SO2, Se and CH2, and with the proviso that at least one of the Xi is not CH2, and with the proviso that if R1 is an alkyne or alkene, then the carbon-carbon triple bond or double bond is positioned between the ( w-1) carbon and the ( w-2) carbon, or between the ( w-2) carbon and the ( w-3) carbon, or between the ( w-3) carbon and the ( w-4) carbon.
Patent NZ-529039-A (NZ)
Title: Vaccine composition comprising at least one human HIV antigen and one or both of HSV and HPV antigens
Inventor: DEBRUS SERGE
IPC: A61K48/00
Filed: 2002-04-25
Abstract: Described are vaccine composition comprising at least one human immunodeficiency virus (HIV) antigen in the form of an HIV envelope protein or HIV Nef protein and either one or both of: I) at least one herpes simplex virus (HSV) glycoprotein D antigen and ii) at least one human papillomavirus (HPV) particle comprising the L1 protein or C terminal truncation thereof. Simultaneous or co-administration of antigens from these viruses provokes an enhanced immune response against all antigens,
Patent NZ-529900-A (NZ)
Title: Multi-channel cooling die
Inventor: HOWSAM STUART
IPC: A23P1/12
Filed: 2002-07-05
Abstract: A cooling die, for use in the manufacture of extruded food products, the cooling die including: a plurality of core members forming a main body portion of the cooling die between die inlet and outlet ends and arranged about an axis of the die in neighboring relationship; a plurality of extrudate flow channels extending through the cooling die from the inlet end to the outlet end, defined by gaps between neighboring ones of the core members; at least one bore in each core member through which coolant may flow; an enclosing structure adapted to secure the core members against radial movement relative to the die axis; means for connecting the cooling die to an outlet of a food extruder, a cooling fluid source and a cooling fluid receptacle; and extrudate flow distribution means, located adjacent the inlet end, adapted to direct extrudate from the outlet of the food extruder into selected ones of the extrudate flow channels.
Patent NZ-531233-A (NZ)
Title: Smoking articles and smokable filler materials therefor
Inventor: DITTRICH DAVID JOHN
IPC: A24B/
Filed: 2002-08-21
Abstract: A smoking material comprising a non-combustible inorganic filler, a binder and aerosol generating means, the non-combustible filler comprising a proportion of material having a mean particle size in the range of 500 to 20 micrometers, the non-combustible inorganic filler being present in the range of 75-90% by weight of the smoking material, and the binder comprising an alginic binder present in the amount of at least 50% of the total amount of binder.
Patent NZ-536600-A (NZ)
Title: Substituted sulphone and sulphonamide compounds useful for the treatment of obesity, type II diabetes and CNS disorders
Inventor: JOHANSSON GARY
IPC: A61P25/00
Filed: 2003-06-19
Abstract: The disclosure relates to compounds of the general formula (I), wherein P is sulfone or sulfonamide; and A, B, W, X, Y and R3 are as defined in the specification; to pharmaceutical compositions comprising these compounds, and to the use of the compounds for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes, and/or CNS disorders, to achieve reduction of body weight and of body weight gain.
Patent NZ-537345-A (NZ)
Title: IgG Fc/HIV-gp120/C3d fusion protein
Inventor: HAYNES BARTON F
IPC: A61K39/00
Filed: 2003-07-23
Abstract: Disclosed is a fusion protein comprising: i) an IgG Fc component ii) an HIV envelope component, and iii) a C3D component. Also disclosed is the use of the above fusion protein for inducing an immune response in a mammal.
Patent NZ-538475-A (NZ)
Title: An evaporation apparatus with inflatable chamber having pool of liquid
Inventor: KNEEBONE HOWARD
IPC: F26B3/28
Filed: 2003-09-01
Abstract: An evaporation apparatus (10) is shown in the form of an inflatable elongate plastic tube (12) that is fitted with fluid control means in the form of an inlet gas fan (14) and a gas outlet hole (16). The capacity of the inlet gas fan (14) and the size of the outlet hole (16) are matched so that the degree of inflation of the tube (12) can be maintained. In use the inflated tube (12) is partially filled with a volume of liquid (18) in a pool at a base thereof to be heated and evaporated by solar radiation and carried out of the tube (12) by a flow of gas therethrough. The pool of liquid (18) may include solid matter (19), or even contain substances such as dissolved solids or salts. Over time a significant quantity of this material can become deposited in the tube (12), and can be reclaimed.
Patent NZ-540031-A (NZ)
Title: Drug delivery device and method
Inventor: WHARTON DAVID PETER
IPC: B63C11/22
Filed: 2003-11-14
Abstract: Disclosed is a breathing apparatus for medicating an air stream, comprising a breathing apparatus (139), a medication chamber (138) adapted to store and discharge a therapeutic agent, a delivery pathway (141) between the chamber (138) and an intake air pathway, and releasing means (145) for selectively discharging the therapeutic agent from the chamber (138) into the intake air pathway. The apparatus is particularly suited for scuba diving, snorkels, gas masks and filters. The apparatus is suitable for asthma sufferers but also extends to other respiratory diseases. Also claimed are a medication chamber for use in medicating an air stream and a method of medicating an air stream.
Patent NZ-543861-A (NZ)
Title: Yarn for an artificial turf ground cover, artificial turf ground cover and playing field including such a yarn and method for producing such a yarn
Inventor: ATSMA FRANKE
IPC: E01C13/08
Filed: 2003-05-28
Abstract: A yarn for strands of an artificial turf ground cover, including a tape filament ( 4 ) having a core layer ( 8 ) and two outer layers ( 9 ) of a different material than the core layer ( 8 ), each on one of two opposite sides of the core layer. The core layer ( 8 ) contains at least polyester or polyolefin material, and the outer layers ( 9 ) contain high-density polyethylene. An artificial turf ground cover and a playing field including such a yarn and a method for producing such a yarn are also described. The high-density polyethylene has a relatively small coefficient of friction with the human skin and the yarn has a good shape recovery after deformation in spite of containing HDPE in outer layers.